02.13.2024 - By Theral Timpson
This is a free preview of a paid episode. To hear more, visit www.mendelspod.com
0:00 Long reads at scale has made what difference?6:15 The long or short of it: How does one decide?12:31 Long reads in the clinic20:37 Apton tech to compete with Illumina’s NovaSeq X26:30 Plans for next instruments35:00 Surveying the competitionIn our first post-AGBT show of the year, we’re talking with the CEO of Pacific Biosciences, Ch…